Sean Lie Sells 710,247 Shares of Cerebras Systems (NASDAQ:CBRS) Stock

Cerebras Systems Inc. (NASDAQ:CBRS) CTO Sean Lie sold 710,247 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $207.86, for a total transaction of $147,631,941.42. Following the sale, the chief technology officer owned 368,926 shares of the company’s stock, valued at approximately $76,684,958.36. This represents a 65.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Sean Lie also recently made the following trade(s):

• On Friday, August 21st, Sean Lie sold 16,293 shares of Cerebras Systems stock. The stock was sold at an average price of $210.01, for a total value of $3,421,692.93.
• On Tuesday, August 18th, Sean Lie sold 21,257 shares of Cerebras Systems stock. The stock was sold at an average price of $222.22, for a total value of $4,723,730.54.
• On Thursday, June 25th, Sean Lie sold 10,033 shares of Cerebras Systems stock. The shares were sold at an average price of $170.07, for a total value of $1,706,312.31.

Cerebras Systems Trading Down 6.5%

Shares of NASDAQ:CBRS opened at $196.13 on Friday. Cerebras Systems Inc. has a one year low of $160.81 and a one year high of $386.34. The company’s 50-day moving average is $208.25.

Cerebras Systems (NASDAQ:CBRS) last released its quarterly earnings results on Wednesday, August 12th. The company reported ($2.98) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($2.77). The business had revenue of $209.87 million during the quarter. Cerebras Systems’s revenue was up 74.3% on a year-over-year basis. On average, equities analysts forecast that Cerebras Systems Inc. will post -0.52 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Wedbush raised their price objective on shares of Cerebras Systems from $280.00 to $290.00 and gave the stock an “outperform” rating in a report on Thursday, August 13th. UBS Group lifted their price target on Cerebras Systems from $320.00 to $330.00 and gave the stock a “buy” rating in a research note on Thursday, August 13th. Rosenblatt Securities reiterated a “buy” rating and issued a $300.00 target price on shares of Cerebras Systems in a research report on Wednesday. Barclays initiated coverage on Cerebras Systems in a report on Monday, June 8th. They issued an “overweight” rating and a $280.00 price target for the company. Finally, TD Cowen started coverage on Cerebras Systems in a research report on Monday, June 8th. They set a “buy” rating and a $275.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $299.90.

Hedge Funds Weigh In On Cerebras Systems

A number of institutional investors and hedge funds have recently bought and sold shares of CBRS. Fortitude Advisory Group L.L.C. bought a new stake in shares of Cerebras Systems during the 2nd quarter worth about $705,000. Value Aligned Research Advisors LLC acquired a new position in Cerebras Systems during the second quarter worth about $241,934,000. Raiffeisen Bank International AG bought a new stake in Cerebras Systems in the second quarter worth about $4,323,000. Situational Awareness LP acquired a new stake in Cerebras Systems in the 2nd quarter valued at about $2,210,000. Finally, Knollwood Investment Advisory LLC acquired a new position in shares of Cerebras Systems in the 2nd quarter worth approximately $4,576,000.

Cerebras Systems News Summary

Here are the key news stories impacting Cerebras Systems this week:

• Positive Sentiment: Cerebras’ new CS-4 accelerator is being promoted as a high-performance, power-efficient solution for AI inference, potentially helping the company compete with NVIDIA and AMD as demand for cloud-based AI computing expands. The performance claims still require broader customer validation. CS-4 and competition article
• Positive Sentiment: Cerebras partnered with Callosum to provide ultra-low-latency, heterogeneous AI inference for agentic applications. The agreement could expand Cerebras’ commercial reach in real-time AI workloads. Cerebras and Callosum partnership
• Positive Sentiment: Rosenblatt Securities and Needham & Company reiterated “Buy” ratings, with reported price targets near $300. The positive analyst view reflects optimism about Cerebras’ AI infrastructure growth, though it has not offset near-term selling pressure. Rosenblatt rating Needham rating
• Positive Sentiment: Call-option activity was about 42% above normal, indicating that some traders are positioning for a rebound or further upside. CBRS options activity
• Neutral Sentiment: Cerebras generated $209.9 million in quarterly revenue, up 74.3% year over year, but the growth has yet to translate into profitability. Investors are focused on whether CS-4 demand can improve margins and earnings.
• Negative Sentiment: Senior executives sold roughly $20.3 million of CBRS stock in transactions dated August 18, including sales by the CEO, COO, CTO and CAO. The filings state the shares were sold to cover tax withholding related to vested equity awards, reducing the bearish signal, but the scale of the transactions may still weigh on sentiment.
• Negative Sentiment: The company’s latest quarterly loss of $2.98 per share was far worse than the expected $0.21 loss. The large earnings miss, despite rapid revenue growth, raises concerns about execution, cash usage and the stock’s elevated valuation.

About Cerebras Systems

Cerebras Systems is a technology company focused on building artificial intelligence infrastructure, including hardware and software designed to accelerate deep learning and large-scale AI workloads. The company is best known for its wafer-scale processor architecture, which is intended to provide high-performance compute for training and inference applications.

In addition to its AI chips, Cerebras offers systems and related software tools that support researchers and enterprises working with machine learning models.